Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Source: 
Xconomy
snippet: 

According to IPO research firm Renaissance Capital, 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Just as last year, healthcare IPOs lead the way. To date in 2019, 23 healthcare-related companies have gone public, the most of any sector.